25 results
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
13 Sep 23
Regulation FD Disclosure
7:00am
Malignancy 1. NIH NCI Surveillance Cancer Facts Leukemia - AML 2. AbbVie VENCLEXTA (venetoclax) Package Insert
40 ZN-d5 + Azenosertib Combination Treatment
10-K
EX-10.12
ohrk5o pw2k60j98z2j
25 Mar 21
Annual report
7:17am
10-K
gc1w39jo m5mpa
25 Mar 21
Annual report
7:17am
8-K
EX-10.1
fu0m1vsczh2xr
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
424B4
1rhb42lqp5vh
31 Jul 20
Prospectus supplement with pricing info
12:00am
DRS
xtgsrfuyp063rgkuekq
10 Jul 20
Draft registration statement
12:00am
DRS
EX-10.5
xaq9jifnt8h6bro47jh
10 Jul 20
Draft registration statement
12:00am
DRS
EX-10.7
ogin3bii2ut
10 Jul 20
Draft registration statement
12:00am
10-Q
68idcwz5nczlav
15 May 20
Quarterly report
7:25am
424B4
d1eo0jhm26 b8js3
6 Apr 20
Prospectus supplement with pricing info
6:13am